These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Adverse effects associated with use of nevirapine in HIV postexposure prophylaxis for 2 health care workers. Johnson S; Baraboutis JG JAMA; 2000 Dec; 284(21):2722-3. PubMed ID: 11105175 [No Abstract] [Full Text] [Related]
4. Adverse effects associated with use of nevirapine in HIV postexposure prophylaxis for 2 health care workers. Sha BE; Proia LA; Kessler HA JAMA; 2000 Dec; 284(21):2723. PubMed ID: 11105176 [No Abstract] [Full Text] [Related]
5. Nevirapine and postexposure prophylaxis for human immunodeficiency virus. Haehl M JAMA; 2001 Feb; 285(7):883. PubMed ID: 11180728 [No Abstract] [Full Text] [Related]
6. Most common prescribing error in postexposure prophylaxis of HIV/AIDS. Mahajan A; Sharma H; Bhagat A; Tandon VR; Sharma R; Sharma S J Assoc Physicians India; 2007 Mar; 55():246-7. PubMed ID: 17598343 [No Abstract] [Full Text] [Related]
7. Prophylaxis with a nevirapine-containing triple regimen after exposure to HIV-1. Benn PD; Mercey DE; Brink N; Scott G; Williams IG Lancet; 2001 Mar; 357(9257):687-8. PubMed ID: 11247556 [TBL] [Abstract][Full Text] [Related]
9. Reports on nevirapine threaten public health. Lane HC; Folkers GK; Fauci AS Nat Med; 2005 Mar; 11(3):245. PubMed ID: 15746930 [No Abstract] [Full Text] [Related]
10. Nevirapine: a review of its use in the prevention and treatment of paediatric HIV infection. Bardsley-Elliot A; Perry CM Paediatr Drugs; 2000; 2(5):373-407. PubMed ID: 11022799 [TBL] [Abstract][Full Text] [Related]
11. Nevirapine to prevent HIV transmission via breastfeeding. Phadke MA; Bulakh PM; Kshirsagar NA Lancet; 2008 Jul; 372(9635):287. PubMed ID: 18657698 [No Abstract] [Full Text] [Related]
12. From the Centers for Disease Control and Prevention. Serious adverse events attributed to nevirapine regimens for postexposure prophylaxis after HIV exposures--worldwide, 1997-2000. JAMA; 2001 Jan 24-31; 285(4):402-3. PubMed ID: 11263401 [No Abstract] [Full Text] [Related]
13. HIV transmission. Allegations raise fears of backlash against AIDS prevention strategy. Cohen J Science; 2004 Dec; 306(5705):2168-9. PubMed ID: 15618490 [No Abstract] [Full Text] [Related]
14. [Reliable effectiveness for years with good long-term tolerance: 10 years nevirapine--a summary]. MMW Fortschr Med; 2008 Apr; 150 Spec No 1():70. PubMed ID: 19024921 [No Abstract] [Full Text] [Related]
15. DRESS (drug rash with eosinophilia and systemic symptoms) syndrome associated with nevirapine therapy. Bourezane Y; Salard D; Hoen B; Vandel S; Drobacheff C; Laurent R Clin Infect Dis; 1998 Nov; 27(5):1321-2. PubMed ID: 9827291 [No Abstract] [Full Text] [Related]
16. Leukocytopenia due to zidovudine- and nevirapine-containing regimens in elderly patients with HIV infection. Yamamoto Y; Yasuoka A; Yasuoka C; Genka I; Teruya K; Kikuchi Y; Tachikawa N; Oka S Jpn J Infect Dis; 2000 Dec; 53(6):244-5. PubMed ID: 11227023 [No Abstract] [Full Text] [Related]
17. AIDS research. IOM panel clears HIV prevention study. Couzin J Science; 2005 Apr; 308(5720):334. PubMed ID: 15831722 [No Abstract] [Full Text] [Related]
18. HIV infection. Talbot M Clin Evid; 2005 Dec; (14):802-17. PubMed ID: 16620438 [No Abstract] [Full Text] [Related]
19. HIV infection. Talbot M Clin Evid; 2006 Jun; (15):937-54. PubMed ID: 16973039 [No Abstract] [Full Text] [Related]